OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials
Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert, et al.
Allergy (2021) Vol. 77, Iss. 4, pp. 1231-1244
Open Access | Times Cited: 71
Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert, et al.
Allergy (2021) Vol. 77, Iss. 4, pp. 1231-1244
Open Access | Times Cited: 71
Showing 1-25 of 71 citing articles:
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 159
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 159
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP ): A multicentric observational Phase IV real‐life study (DUPIREAL )
Eugenio De Corso, Ernesto Pasquini, Matteo Trimarchi, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2669-2683
Open Access | Times Cited: 79
Eugenio De Corso, Ernesto Pasquini, Matteo Trimarchi, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2669-2683
Open Access | Times Cited: 79
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
Joaquim Mullol, Claus Bachert, Nikhil Amin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 4, pp. 1086-1095.e5
Open Access | Times Cited: 74
Joaquim Mullol, Claus Bachert, Nikhil Amin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 4, pp. 1086-1095.e5
Open Access | Times Cited: 74
IL-4Rα signaling promotes barrier-altering oncostatin M and IL-6 production in aspirin-exacerbated respiratory disease
Chongjia C. Chen, Kathleen M. Buchheit, Pui Y. Lee, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 2, pp. 458-467.e3
Closed Access | Times Cited: 8
Chongjia C. Chen, Kathleen M. Buchheit, Pui Y. Lee, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 2, pp. 458-467.e3
Closed Access | Times Cited: 8
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID ‐exacerbated respiratory disease
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3593-3605
Closed Access | Times Cited: 29
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3593-3605
Closed Access | Times Cited: 29
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy
Claus Bachert, Amber Luong, Philippe Gevaert, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2630-2641
Open Access | Times Cited: 21
Claus Bachert, Amber Luong, Philippe Gevaert, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2630-2641
Open Access | Times Cited: 21
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
Peter W. Hellings, Isam Alobid, Wilma Terezinha Anselmo‐Lima, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1123-1133
Open Access | Times Cited: 21
Peter W. Hellings, Isam Alobid, Wilma Terezinha Anselmo‐Lima, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1123-1133
Open Access | Times Cited: 21
Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Martina Ragusa, Federico Sireci, et al.
American Journal of Otolaryngology (2023) Vol. 45, Iss. 1, pp. 104106-104106
Open Access | Times Cited: 19
Cosimo Galletti, Martina Ragusa, Federico Sireci, et al.
American Journal of Otolaryngology (2023) Vol. 45, Iss. 1, pp. 104106-104106
Open Access | Times Cited: 19
The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics
A. Wautlet, Claus Bachert, Martin Desrosiers, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2642-2651
Closed Access | Times Cited: 17
A. Wautlet, Claus Bachert, Martin Desrosiers, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2642-2651
Closed Access | Times Cited: 17
Nonsteroidal Anti-inflammatory Drug (NSAID) Tolerance After Biological Therapy in Patients With NSAID-Exacerbated Respiratory Disease: A Randomized Comparative Trial
Jorge Sánchez, Elizabeth García, Juan‐Felipe Lopez, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 7, pp. 2172-2179
Closed Access | Times Cited: 16
Jorge Sánchez, Elizabeth García, Juan‐Felipe Lopez, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 7, pp. 2172-2179
Closed Access | Times Cited: 16
Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results
Claus Bachert, Tanya M. Laidlaw, Seong Cho, et al.
Annals of Otology Rhinology & Laryngology (2023) Vol. 132, Iss. 12, pp. 1649-1661
Open Access | Times Cited: 14
Claus Bachert, Tanya M. Laidlaw, Seong Cho, et al.
Annals of Otology Rhinology & Laryngology (2023) Vol. 132, Iss. 12, pp. 1649-1661
Open Access | Times Cited: 14
Aspirin-exacerbated respiratory disease
Jyotsna Mullur, Kathleen M. Buchheit
Annals of Allergy Asthma & Immunology (2023) Vol. 131, Iss. 3, pp. 317-324
Open Access | Times Cited: 13
Jyotsna Mullur, Kathleen M. Buchheit
Annals of Allergy Asthma & Immunology (2023) Vol. 131, Iss. 3, pp. 317-324
Open Access | Times Cited: 13
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Biologikatherapie bei schwer erkrankten Patienten mit „NSAID-exacerbated respiratory disease“ und stattgehabter ASS‑Desaktivierung
Anna-Rebekka Staufenberg, H. Frankenberger, Ulrike Förster‐Ruhrmann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 473-483
Open Access | Times Cited: 5
Anna-Rebekka Staufenberg, H. Frankenberger, Ulrike Förster‐Ruhrmann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 473-483
Open Access | Times Cited: 5
Management of United Airway Disease Focused on Patients With Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review
Joaquim Mullol, Miguel J. Maldonado, José A. García del Castillo, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 9, pp. 2438-2447.e9
Closed Access | Times Cited: 21
Joaquim Mullol, Miguel J. Maldonado, José A. García del Castillo, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 9, pp. 2438-2447.e9
Closed Access | Times Cited: 21
Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
Sven Schneider, Katharina Poglitsch, Christina Morgenstern, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 3, pp. 2201335-2201335
Open Access | Times Cited: 21
Sven Schneider, Katharina Poglitsch, Christina Morgenstern, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 3, pp. 2201335-2201335
Open Access | Times Cited: 21
Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease—How to Choose
Tanya M. Laidlaw, Derek K. Chu, Whitney W. Stevens, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1462-1467
Closed Access | Times Cited: 20
Tanya M. Laidlaw, Derek K. Chu, Whitney W. Stevens, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1462-1467
Closed Access | Times Cited: 20
A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012–2022
Robert M. Naclerio, Joaquim Mullol, Whitney W. Stevens
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 1, pp. 43-50
Closed Access | Times Cited: 11
Robert M. Naclerio, Joaquim Mullol, Whitney W. Stevens
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 1, pp. 43-50
Closed Access | Times Cited: 11
Mechanistic and clinical updates in AERD: 2021-2022
Whitney W. Stevens, Katherine N. Cahill
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 6, pp. 1448-1456
Open Access | Times Cited: 11
Whitney W. Stevens, Katherine N. Cahill
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 6, pp. 1448-1456
Open Access | Times Cited: 11
Tezepelumab improved chronic rhinosinusitis with nasal polyps in a Patient with aspirin exacerbated respiratory disease
Yuga Yamashita, Kosuke Terada, Yuka Kodama, et al.
Respiratory Medicine Case Reports (2024) Vol. 50, pp. 102041-102041
Open Access | Times Cited: 4
Yuga Yamashita, Kosuke Terada, Yuka Kodama, et al.
Respiratory Medicine Case Reports (2024) Vol. 50, pp. 102041-102041
Open Access | Times Cited: 4
Outcome measures for chronic rhinosinusitis with nasal polyps
Ahmad R. Sedaghat, Raewyn G. Campbell, Richard Douglas, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 4
Ahmad R. Sedaghat, Raewyn G. Campbell, Richard Douglas, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 4
Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR)
Sven Seys, Sven Schneider, Joost de Kinderen, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 4
Sven Seys, Sven Schneider, Joost de Kinderen, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 4
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
